MX340508B - Derivados de pirrolidina como antagonistas del receptor de neuroquinina 3 (nk3). - Google Patents

Derivados de pirrolidina como antagonistas del receptor de neuroquinina 3 (nk3).

Info

Publication number
MX340508B
MX340508B MX2013007411A MX2013007411A MX340508B MX 340508 B MX340508 B MX 340508B MX 2013007411 A MX2013007411 A MX 2013007411A MX 2013007411 A MX2013007411 A MX 2013007411A MX 340508 B MX340508 B MX 340508B
Authority
MX
Mexico
Prior art keywords
lower alkyl
substituted
halogen
phenyl
pyridazinyl
Prior art date
Application number
MX2013007411A
Other languages
English (en)
Spanish (es)
Other versions
MX2013007411A (es
Inventor
Ratni Hasane
Knust Henner
Nettekoven Matthias
Vifian Walter
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2013007411A publication Critical patent/MX2013007411A/es
Publication of MX340508B publication Critical patent/MX340508B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
MX2013007411A 2011-01-07 2012-01-03 Derivados de pirrolidina como antagonistas del receptor de neuroquinina 3 (nk3). MX340508B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11150352 2011-01-07
PCT/EP2012/050034 WO2012093109A1 (en) 2011-01-07 2012-01-03 Pyrrolidine derivatives as nk3 antagonists

Publications (2)

Publication Number Publication Date
MX2013007411A MX2013007411A (es) 2013-07-29
MX340508B true MX340508B (es) 2016-07-11

Family

ID=45443125

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013007411A MX340508B (es) 2011-01-07 2012-01-03 Derivados de pirrolidina como antagonistas del receptor de neuroquinina 3 (nk3).

Country Status (12)

Country Link
US (1) US8618303B2 (ko)
EP (1) EP2661432B1 (ko)
JP (1) JP5763211B2 (ko)
KR (1) KR101522125B1 (ko)
CN (1) CN103282357B (ko)
BR (1) BR112013017059A2 (ko)
CA (1) CA2821640A1 (ko)
ES (1) ES2526420T3 (ko)
HK (1) HK1187914A1 (ko)
MX (1) MX340508B (ko)
RU (1) RU2598604C2 (ko)
WO (1) WO2012093109A1 (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110144081A1 (en) * 2009-12-15 2011-06-16 Henner Knust Pyrrolidine derivatives
US20110152233A1 (en) * 2009-12-18 2011-06-23 Henner Knust Pyrrolidine compounds
MX2014014683A (es) * 2012-06-06 2015-02-24 Bionor Immuno As Peptidos derivados de proteinas virales para usarse como inmunogenos y reactivos de dosificacion.
MX2020003821A (es) 2017-10-10 2023-01-12 Biogen Inc Proceso de elaboración de espiroderivados.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008240804B2 (en) 2007-04-20 2013-02-21 F. Hoffmann-La Roche Ag Pyrrolidine derivatives as dual NK1/NK3 receptor antagonists
ATE486058T1 (de) * 2007-06-07 2010-11-15 Hoffmann La Roche Prolinamidderivate als nk3-antagonisten
JP2010536818A (ja) * 2007-08-22 2010-12-02 エフ.ホフマン−ラ ロシュ アーゲー Nk3受容体アンタゴニストとしてのピロリジンアリール−エーテル
MX2011003312A (es) 2008-10-09 2011-04-26 Hoffmann La Roche Derivados de pirrolidina n-bencilo.
US8022099B2 (en) * 2008-11-03 2011-09-20 Hoffmann-La Roche Inc. N-benzyl pyrrolidine derivatives
US8318759B2 (en) 2009-02-18 2012-11-27 Hoffmann-La Roche Inc. Pyrrolidine derivatives as NK3 receptor antagonists
US20110144081A1 (en) 2009-12-15 2011-06-16 Henner Knust Pyrrolidine derivatives
US20110152233A1 (en) * 2009-12-18 2011-06-23 Henner Knust Pyrrolidine compounds

Also Published As

Publication number Publication date
WO2012093109A1 (en) 2012-07-12
KR20130120508A (ko) 2013-11-04
JP2014501767A (ja) 2014-01-23
KR101522125B1 (ko) 2015-05-20
CN103282357A (zh) 2013-09-04
JP5763211B2 (ja) 2015-08-12
MX2013007411A (es) 2013-07-29
RU2598604C2 (ru) 2016-09-27
US8618303B2 (en) 2013-12-31
EP2661432A1 (en) 2013-11-13
EP2661432B1 (en) 2014-11-19
RU2013135176A (ru) 2015-02-20
CN103282357B (zh) 2014-12-17
CA2821640A1 (en) 2012-07-12
BR112013017059A2 (pt) 2020-10-27
ES2526420T3 (es) 2015-01-12
HK1187914A1 (en) 2014-04-17
US20120178761A1 (en) 2012-07-12

Similar Documents

Publication Publication Date Title
MX361020B (es) Procesos para preparar compuestos heterociclicos, incluida trans-7-oxo-6-(sulfooxi)-1,6-diazabiciclo [3,2,1]octano-2-carboxam ida y sales de la misma.
TNSN08372A1 (en) Heterocyclic amides for use as pharmaceuticals
PH12015502001A1 (en) Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
PH12014502866A1 (en) Fungicidal heterocyclic carboxamides
NZ749437A (en) Processes and intermediates for making a jak inhibitor
NZ630721A (en) Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use
CY1116778T1 (el) Παραγωγα πυραζολιου
MX2010001774A (es) Pirrolidin aril-eteres como antagonistas de receptores de nk3.
EA201391341A1 (ru) Производные гетероциклических аминов
MX2009013115A (es) Derivados de prolinamida como antagonistas de nk3.
PE20141167A1 (es) Piridopirazinas sustituidas como inhibidores novedosos de ptk
JP2012097115A5 (ko)
MX2016008536A (es) Derivados de fluoro-naftilo.
MX2015014353A (es) Derivados de 2-fenil- o 2-hetaril-imidazol[1,2-a]piridina.
MX354815B (es) Derivados heterociclicos como receptores asociados con las aminas traza (taars).
PH12016500427A1 (en) Ethynyl derivatives
MX2011008850A (es) Derivados de piperidina como antagonistas del receptor de neuroquinina 3 (nk3).
MX2013007411A (es) Derivados de pirrolidina como antagonistas del receptor de neuroquinina 3 (nk3).
MX2012001799A (es) Derivados de pirrolidina como antagonistas del receptor de neuroquinona 3 (nk3).
BR112013000253A2 (pt) derivados de (3-metilpirrolidin-3-il) metil piridinil éter e seu uso como antagonistas do receptor nk-3
MX2012006293A (es) Derivados de pirrolidina como antagonista del receptor nk-3.
PE20141168A1 (es) Derivados de pirazolidin-3-ona
MX2011008178A (es) Derivados de pirrolidina como antagonistas del receptor de neuroquinina 3 (nk3).
MX2011007506A (es) Derivados de piperidina como antagonistas del receptor de neuroquinina 3 (nk3).
MX2009006972A (es) Derivados de espiropiperidina como antagonistas de neuroquinina 3.

Legal Events

Date Code Title Description
FG Grant or registration